Department of Radiology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Dentomaxillofac Radiol. 2021 Oct 1;50(7):20200579. doi: 10.1259/dmfr.20200579. Epub 2021 May 6.
Post chemoradiotherapy (CRT) interval changes in apparent diffusion coefficient (ADC) have prognostic value in head and neck squamous cell cancer (HNSCC). The impact of using different region of interest (ROI) methods on interobserver agreement and their ability to reliably detect the changes in the ADC values was assessed.
Following ethical approval, 25 patients (mean age 59.5 years, 21 male) with stage 3-4 HNSCC undergoing CRT were recruited for this prospective cohort study. Diffusion weighted MRI (DW-MRI) was performed pre-treatment and at 6 and 12 weeks following CRT. Two radiologists independently delineated ROIs using whole volume (ROI), largest area (ROI) or representative area (ROI) methods at primary tumour ( = 22) and largest nodal ( = 24) locations and recorded the ADC. When no clear focus of increased DWI signal was evident at follow-up, a standardised ROI was placed (non-measurable or NM). Bland-Altman plots and interclass correlation coefficient (ICC) were assessed. Paired t-tests evaluated interval changes in pre- and post-treatment ADC at each location, which were compared to the smallest detectable difference (SDD).
Excellent agreement was obtained for all ROI methods at pre-treatment (ICC 0.94-0.98) and 6-week post-treatment (ICC 0.94-0.98). At 12-week post-treatment, agreement was excellent (ICC 0.91-0.94) apart from ROI (ICC 0.86) and the NM nodal disease (ICC 0.87). There were significant interval increases in ADC between pre-treatment and post-treatment studies, which were greater than the SDD for all ROIs.
ADC values can be reproducibly obtained in HNSCC using the different ROI techniques on pre- and post-CRT MRI, and this reliably detects the interval changes.
放化疗(CRT)后表观扩散系数(ADC)的变化对头颈部鳞状细胞癌(HNSCC)有预后价值。本研究评估了不同感兴趣区(ROI)方法对观察者间一致性的影响及其检测 ADC 值变化的能力。
本前瞻性队列研究经伦理批准后,招募了 25 名接受 CRT 的 III-IV 期 HNSCC 患者(平均年龄 59.5 岁,21 名男性)。在治疗前和 CRT 后 6 周和 12 周进行弥散加权 MRI(DW-MRI)。两位放射科医生分别使用全容积(ROI)、最大面积(ROI)或代表性区域(ROI)方法在原发肿瘤(=22)和最大淋巴结(=24)部位勾画 ROI,并记录 ADC 值。如果在随访时没有明显的弥散加权成像信号增高焦点,则放置标准 ROI(无法测量或 NM)。采用 Bland-Altman 图和组内相关系数(ICC)评估方法。配对 t 检验评估了每个部位治疗前后 ADC 的间隔变化,并与最小可检测差异(SDD)进行比较。
所有 ROI 方法在治疗前(ICC 0.94-0.98)和治疗后 6 周(ICC 0.94-0.98)均具有极好的一致性。在治疗后 12 周,除 ROI(ICC 0.86)和 NM 淋巴结疾病(ICC 0.87)外,其余均具有极好的一致性(ICC 0.91-0.94)。ADC 值在治疗前后研究中均有显著增加,且所有 ROI 的增加均大于 SDD。
在 HNSCC 的 CRT 前后 MRI 上使用不同的 ROI 技术可以重复获得 ADC 值,并且可以可靠地检测到间隔变化。